Niche nitric oxide Capitalize on Nu-Med Plus’s core focus on precision nitric oxide delivery to target high-need medical markets such as heart and respiratory care, offering a pathway to align with hospitals and patients seeking innovative therapeutic delivery systems.

Clinical applications Explore partnerships around key use cases mentioned including wound care, malaria, COPD, tuberculosis, ARDS and neonatal respiratory support to identify departments and clinicians likely to pilot or adopt new NO-delivery technologies.

Strategic acquisitions Monitor and engage with Nu-Med Plus’s recent and planned M&A activity (e.g., acquisition of Avid Gold and Canadian properties) to position complementary product lines or distribution channels that can widen market access or accelerate go-to-market in North America.

Regulatory readiness Leverage the company’s ISO 13485 certification effort as a selling point to prospects prioritizing compliant medical device suppliers; offer support or partnerships to accelerate regulatory milestones for customer programs.

Financial foothold With modest revenue and near-term funding, present scalable, capital-efficient collaboration opportunities such as co-development agreements, pilot programs, or staged deployments to minimize upfront risk for potential buyers and investors.